IndraLab

Statements


USP11 activates tumor resistance treatment. 1 / 1
| 1

eidos
"Ubiquitin-specific protease 11 ( USP11 ) was reported to induce tumor resistance to treatment through stabilizing downstream proteins by deubiquitination 20 ."